ANOG: Small/Medium CFO/CEO- If They Buy, Might Want To Buy??
Published on July 24, 2017 at 2:32 pm by TIM FREDERICK in Insider Trading,Market Movers,News
Two insiders at AngioDynamics, Inc. (NASDAQ:ANOG), including President and CEO James C. Clemmer, have bought shares of the company in the past week following a bout of weakness. Mr. Clemmer purchased 25,000 shares in total through transactions made on July 20 and 21, lifting his ownership stake to 91,683 shares. Meanwhile, Independent Chairman of the Board Howard W. Donnelly purchased 5,000 shares on July 21, lifting his ownership position to 47,600 shares.
The purchases are particularly notable given the fact that they’re the first made by executives of the company in more than three years. And it’s not as if shares were flying high during that time, which could otherwise have explained the lack of buying; shares of AngioDynamics, Inc. (NASDAQ:ANGO) tanked by over 40% in 2015, yet insiders kept their purse strings cinched. The purchases by the CEO are also the first since he took the reins of the company last April, while Mr. Donnelly’s purchase was his first in eight years.
In my opinion INSIDER SELLING STOCKS, I would consider jump on with them unless technical and fundamentals support this, why? because there are several reasons why people sell stocks, buy their is only ONE reason why CEO/CFO would by stocks.... because they expect it to go up in not distance future.
Just something to think about: You might want to google: Insider trading websites and follow them, because when major insiders are buying especially out of the clear BLUE, must be a big REASON.
Two insiders at AngioDynamics, Inc. (NASDAQ:ANOG), including President and CEO James C. Clemmer, have bought shares of the company in the past week following a bout of weakness. Mr. Clemmer purchased 25,000 shares in total through transactions made on July 20 and 21, lifting his ownership stake to 91,683 shares. Meanwhile, Independent Chairman of the Board Howard W. Donnelly purchased 5,000 shares on July 21, lifting his ownership position to 47,600 shares.
The purchases are particularly notable given the fact that they’re the first made by executives of the company in more than three years. And it’s not as if shares were flying high during that time, which could otherwise have explained the lack of buying; shares of AngioDynamics, Inc. (NASDAQ:ANGO) tanked by over 40% in 2015, yet insiders kept their purse strings cinched. The purchases by the CEO are also the first since he took the reins of the company last April, while Mr. Donnelly’s purchase was his first in eight years.
In my opinion INSIDER SELLING STOCKS, I would consider jump on with them unless technical and fundamentals support this, why? because there are several reasons why people sell stocks, buy their is only ONE reason why CEO/CFO would by stocks.... because they expect it to go up in not distance future.
Just something to think about: You might want to google: Insider trading websites and follow them, because when major insiders are buying especially out of the clear BLUE, must be a big REASON.